Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
QuintilesIMS
Express Scripts
Colorcon
Fuji
Cipla
Teva
Daiichi Sankyo
Chinese Patent Office

Generated: July 18, 2018

DrugPatentWatch Database Preview

Doxercalciferol - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for doxercalciferol and what is the scope of doxercalciferol patent protection?

Doxercalciferol
is the generic ingredient in two branded drugs marketed by Rising Pharms Inc, West-ward Pharms Int, Genzyme Corp, Akorn Inc, Amneal Pharms Co, Hikma Pharms, and Sandoz Inc, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for doxercalciferol. Ten suppliers are listed for this compound. There is one tentative approval for this compound.
Pharmacology for doxercalciferol
Ingredient-typeErgocalciferols
Drug ClassVitamin D2 Analog
Synonyms for doxercalciferol
(1|A,3|A,5Z,7E,22E)- 9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol
(1R,3S,5Z)-4-Methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-7?-methyl-1-[(1R,2E)-1,4,5-trimethyl-2-hexen-1-yl]-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol
(1R,3S,5Z)-4-Methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-7a-methyl-1-[(1R,2E)-1,4,5-trimethyl-2-hexen-1-yl]-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol
(1R,3S,5Z)-4-Methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-7alpha-methyl-1-[(1R,2E)-1,4,5-trimethyl-2-hexen-1-yl]-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol
(1R,3S,Z)-5-(2-((1R,3aS,7aR,E)-1-((2R,5R,E)-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol
(5Z,7E,22E)-(1S,3R)-9,10-seco-5,7,10(19),22-ergostatetraene-1,3-diol
(5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraene-1alpha,3beta-diol
1-alpha-hydroxyergocalciferol
1-alpha-Hydroxyvitamin D2
1-Hydroxyergocalciferol
1-Hydroxyvitamin D2
1?Hydroxy VitaMin D2
1|A-Hydroxy Vitamin D2
1|A-Hydroxyergocalciferol
1|A-Hydroxyvitamin D2
125285-48-5
1alpha-hydroxy vitamin D2
1alpha-Hydroxyergocalciferol
1alpha-hydroxyvitamin D2
1alpha-hydroxyvitamin D2 / 1alpha-hydroxyergocalciferol
1alpha-OH-D2
1alpha-OHD2
1alphaOHD2
3DIZ9LF5Y9
42163-EP2298768A1
42163-EP2311808A1
42163-EP2311829A1
54573-75-0
573D750
87649-67-0
9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol, (1-alpha,3-beta,5Z,7E,22E)-
9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol, (1alpha,3beta,5Z,7E,22E)-
9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol,(1-alpha,3-beta,5Z,7E,22E)
AC1NQY15
ACT06836
AKOS005146517
BCI-101
BRN 4716774
C08211
C28H44O2
CAS-54573-75-0
CHEBI:4712
CHEMBL1200810
CS-0395
D01009
D0G5CF
Doxcercalciferol
Doxercalciferol (INN)
Doxercalciferol [INN]
Doxercalciferol [USAN:INN]
Doxercalciferol, >=98% (HPLC), solubility: >10 mg/mL in DMSO
Doxercalciferol, United States Pharmacopeia (USP) Reference Standard
DSSTox_CID_14214
DSSTox_GSID_34214
DSSTox_RID_79125
DTXSID1034214
GTPL2790
Hectorol
Hectorol (TN)
HKXBNHCUPKIYDM-CGMHZMFXSA-N
HSCI1_000341
HY-32348
LMST03010028
LS-144720
MFCD00871065
MolPort-018-493-676
NCGC00182058-03
OR009085
PubChem18823
SC-77181
SCHEMBL322422
Tox21_112978
TSA 840
UNII-3DIZ9LF5Y9
V1826
Vitamin D2, 1alpha-Hydroxy-
W-5181
ZINC4641374
Tentative approvals for DOXERCALCIFEROL
Applicant Application No. Strength Dosage Form
➤ Try a Free Trial➤ Try a Free Trial2MCG/MLINJECTABLE; INJECTION

US Patents and Regulatory Information for doxercalciferol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn Inc DOXERCALCIFEROL doxercalciferol INJECTABLE;INJECTION 203929-002 Mar 28, 2016 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Akorn Inc DOXERCALCIFEROL doxercalciferol INJECTABLE;INJECTION 203929-001 May 7, 2015 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Rising Pharms Inc DOXERCALCIFEROL doxercalciferol CAPSULE;ORAL 201518-003 Sep 9, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Rising Pharms Inc DOXERCALCIFEROL doxercalciferol CAPSULE;ORAL 201518-002 Sep 9, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for doxercalciferol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Genzyme Corp HECTOROL doxercalciferol CAPSULE;ORAL 020862-001 Jun 9, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Genzyme Corp HECTOROL doxercalciferol CAPSULE;ORAL 020862-001 Jun 9, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Genzyme Corp HECTOROL doxercalciferol CAPSULE;ORAL 020862-002 Apr 23, 2004 ➤ Try a Free Trial ➤ Try a Free Trial
Genzyme Corp HECTOROL doxercalciferol CAPSULE;ORAL 020862-001 Jun 9, 1999 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Cantor Fitzgerald
Chinese Patent Office
Medtronic
Boehringer Ingelheim
Covington
McKesson
Healthtrust
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.